H. GILLIJNS

Publication List Details

Period

1998 - 2007

Number

23

Co-Authors

L-arginine administration reduces neointima formation after stent injury in rats by a nitric oxide-mediated mechanism (2001)

Nong, Z, Stabile, E, Varenne, O, Gillijns, H, ...

The clinical outcome of vascular stenting is limited by in-stent stenosis. Increased nitric oxide (NO)/cGMP signaling by L-arginine (L-Arg) supplementation, the substrate for NO synthase (NOS), or...

Soluble guanylate cyclase alpha(1) and beta(1) gene transfer increases NO responsiveness and reduces neointima formation after balloon injury in rats via antiproliferative and antimigratory effects (2001)

Chiche, J D, Nong, Z, Varenne, O, Van Pelt, N, Gillijns, H, ...

In vascular smooth muscle cells, NO stimulates the synthesis of cGMP by soluble guanylate cyclase (sGC), a heterodimer composed of alpha(1) and beta(1) subunits. NO/cGMP signal transduction affects...

Aerosol gene transfer with inducible nitric oxide synthase reduces hypoxic pulmonary hypertension and pulmonary vascular remodeling in rats (2000)

Budts, Werner; U0037749, Nong, ZX, Van Pelt, N, Gillijns, H, Gerard, R, ...

BACKGROUND: Nitric oxide (NO) is a potent vasodilator with an important role in the regulation of pulmonary vascular tone. The effects of NO synthase (NOS) gene transfer on pulmonary vascular...

Percutaneous gene therapy using recombinant adenoviruses encoding human herpes simplex virus thymidine kinase, human PAI-1, and human NOS3 in balloon-injured porcine coronary arteries (2000)

Gillijns, H, Iung, B, Meurrens, K, ...

Local intracoronary delivery of recombinant adenoviruses expressing anti-migratory or anti-proliferative proteins including human constitutive endothelial nitric oxide synthase (NOS3), plasminogen...